Suppr超能文献

优化斑马鱼幼鱼游泳性能检测方法以用于药物发现。

Optimizing assays of zebrafish larvae swimming performance for drug discovery.

机构信息

Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.

The Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA.

出版信息

Expert Opin Drug Discov. 2023 Jun;18(6):629-641. doi: 10.1080/17460441.2023.2211802. Epub 2023 May 15.

Abstract

INTRODUCTION

Zebrafish larvae are one of the few vertebrates amenable to large-scale drug discovery screens. Larval swimming behavior is often used as an outcome variable and many fields of study have developed assays for evaluating swimming performance. An unintended consequence of this wide interest is that details related to assay methodology and interpretation become scattered across the literature. The aim of this review is to consolidate this information, particularly as it relates to high-throughput approaches.

AREAS COVERED

The authors describe larval swimming behaviors as this forms the basis for understanding their experimentally evoked swimming or spontaneous activity. Next, they detail how swimming activity can serve as an outcome variable, particularly in the multi-well formats used in large-scale screening studies. They also highlight biological and technical factors that can impact the sensitivity and variability of these measurements.

EXPERT OPINION

Careful attention to animal husbandry, experimental design, data acquisition, and interpretation of results can improve screen outcomes by maximizing swimming activity while minimizing intra- and inter-larval variability. The development of more sensitive, quantitative methods of assessing swimming performance that can be incorporated into high-throughput workflows will be important in order to take full advantage of the zebrafish model.

摘要

简介

斑马鱼幼鱼是少数几种适合大规模药物发现筛选的脊椎动物之一。幼鱼的游泳行为通常用作结果变量,许多研究领域已经开发出用于评估游泳性能的测定方法。这种广泛关注的一个意外后果是,与测定方法学和解释相关的细节在文献中分散开来。本综述的目的是整合这些信息,特别是与高通量方法相关的信息。

涵盖领域

作者描述了幼鱼的游泳行为,因为这是理解其实验诱发的游泳或自发活动的基础。接下来,他们详细介绍了游泳活动如何作为一个结果变量,特别是在用于大规模筛选研究的多孔板格式中。他们还强调了可能影响这些测量的灵敏度和可变性的生物学和技术因素。

专家意见

通过最大限度地提高游泳活动,同时最小化个体内和个体间的变异性,仔细注意动物饲养、实验设计、数据采集和结果解释,可以改善筛选结果。开发更敏感、定量的游泳性能评估方法,并将其纳入高通量工作流程,对于充分利用斑马鱼模型将是重要的。

相似文献

1
Optimizing assays of zebrafish larvae swimming performance for drug discovery.
Expert Opin Drug Discov. 2023 Jun;18(6):629-641. doi: 10.1080/17460441.2023.2211802. Epub 2023 May 15.
3
Movement and function of the pectoral fins of the larval zebrafish (Danio rerio) during slow swimming.
J Exp Biol. 2011 Sep 15;214(Pt 18):3111-23. doi: 10.1242/jeb.057497.
5
Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine.
Aquat Toxicol. 2016 Jan;170:344-354. doi: 10.1016/j.aquatox.2015.09.011. Epub 2015 Sep 25.
6
Triploidy in zebrafish larvae: Effects on gene expression, cell size and cell number, growth, development and swimming performance.
PLoS One. 2020 Mar 2;15(3):e0229468. doi: 10.1371/journal.pone.0229468. eCollection 2020.
7
Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract.
Psychopharmacology (Berl). 2016 Jul;233(13):2533-47. doi: 10.1007/s00213-016-4304-z. Epub 2016 May 11.
9
Flow patterns of larval fish: undulatory swimming in the intermediate flow regime.
J Exp Biol. 2008 Jan;211(Pt 2):196-205. doi: 10.1242/jeb.005629.
10
Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs.
J Pharmacol Toxicol Methods. 2008 May-Jun;57(3):176-87. doi: 10.1016/j.vascn.2008.01.004. Epub 2008 Feb 9.

引用本文的文献

1
Divergent spatiotemporal integration of whole-field visual motion in medaka and zebrafish.
bioRxiv. 2025 Aug 27:2025.08.22.671687. doi: 10.1101/2025.08.22.671687.
4
Automated detection of complex zebrafish seizure behavior at scale.
Commun Biol. 2025 Jun 5;8(1):872. doi: 10.1038/s42003-025-08310-6.
6
High resolution kinematic approach for quantifying impaired mobility of dystrophic zebrafish larvae.
bioRxiv. 2024 Dec 9:2024.12.05.627004. doi: 10.1101/2024.12.05.627004.
7
Standardization of zebrafish drug testing parameters for muscle diseases.
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050339. Epub 2024 Jan 18.

本文引用的文献

1
Using a variant of the optomotor response as a visual defect detection assay in zebrafish.
J Biol Methods. 2021 Feb 1;8(1):e144. doi: 10.14440/jbm.2021.341. eCollection 2021.
2
A Customizable Low-Cost System for Massively Parallel Zebrafish Behavioral Phenotyping.
Front Behav Neurosci. 2021 Jan 18;14:606900. doi: 10.3389/fnbeh.2020.606900. eCollection 2020.
3
PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
Mol Ther. 2021 Mar 3;29(3):1086-1101. doi: 10.1016/j.ymthe.2020.11.021. Epub 2020 Nov 20.
4
Quantification of the influence of drugs on zebrafish larvae swimming kinematics and energetics.
PeerJ. 2020 Jan 8;8:e8374. doi: 10.7717/peerj.8374. eCollection 2020.
6
Emergence of consistent intra-individual locomotor patterns during zebrafish development.
Sci Rep. 2019 Sep 20;9(1):13647. doi: 10.1038/s41598-019-49614-y.
7
Reorientation and propulsion in fast-starting zebrafish larvae: an inverse dynamics analysis.
J Exp Biol. 2019 Jul 17;222(Pt 14):jeb203091. doi: 10.1242/jeb.203091.
8
Discovery of Novel Therapeutics for Muscular Dystrophies using Zebrafish Phenotypic Screens.
J Neuromuscul Dis. 2019;6(3):271-287. doi: 10.3233/JND-190389.
9
Microfluidic devices for embryonic and larval zebrafish studies.
Brief Funct Genomics. 2019 Nov 19;18(6):419-432. doi: 10.1093/bfgp/elz006.
10
Stytra: An open-source, integrated system for stimulation, tracking and closed-loop behavioral experiments.
PLoS Comput Biol. 2019 Apr 8;15(4):e1006699. doi: 10.1371/journal.pcbi.1006699. eCollection 2019 Apr.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验